146 related articles for article (PubMed ID: 33797775)
1. Toll-like receptor activation of equine mesenchymal stromal cells to enhance antibacterial activity and immunomodulatory cytokine secretion.
Pezzanite LM; Chow L; Johnson V; Griffenhagen GM; Goodrich L; Dow S
Vet Surg; 2021 May; 50(4):858-871. PubMed ID: 33797775
[TBL] [Abstract][Full Text] [Related]
2. Comparison of Antibacterial and Immunological Properties of Mesenchymal Stem/Stromal Cells from Equine Bone Marrow, Endometrium, and Adipose Tissue.
Cortés-Araya Y; Amilon K; Rink BE; Black G; Lisowski Z; Donadeu FX; Esteves CL
Stem Cells Dev; 2018 Nov; 27(21):1518-1525. PubMed ID: 30044182
[TBL] [Abstract][Full Text] [Related]
3. TLR-activated mesenchymal stromal cell therapy and antibiotics to treat multi-drug resistant
Pezzanite LM; Chow L; Phillips J; Griffenhagen GM; Moore AR; Schaer TP; Engiles JB; Werpy N; Gilbertie J; Schnabel LV; Antczak D; Miller D; Dow S; Goodrich LR
Ann Transl Med; 2022 Nov; 10(21):1157. PubMed ID: 36467344
[TBL] [Abstract][Full Text] [Related]
4. Effects of continuous passage on the immunomodulatory properties of equine bone marrow-derived mesenchymal stem cells in vitro.
Connard SS; Linardi RL; Even KM; Berglund AK; Schnabel LV; Ortved KF
Vet Immunol Immunopathol; 2021 Apr; 234():110203. PubMed ID: 33636546
[TBL] [Abstract][Full Text] [Related]
5. Antimicrobial peptides secreted by equine mesenchymal stromal cells inhibit the growth of bacteria commonly found in skin wounds.
Harman RM; Yang S; He MK; Van de Walle GR
Stem Cell Res Ther; 2017 Jul; 8(1):157. PubMed ID: 28676123
[TBL] [Abstract][Full Text] [Related]
6. The immunomodulatory function of equine MSCs is enhanced by priming through an inflammatory microenvironment or TLR3 ligand.
Cassano JM; Schnabel LV; Goodale MB; Fortier LA
Vet Immunol Immunopathol; 2018 Jan; 195():33-39. PubMed ID: 29249315
[TBL] [Abstract][Full Text] [Related]
7. Antibacterial effect of human mesenchymal stem cells is mediated in part from secretion of the antimicrobial peptide LL-37.
Krasnodembskaya A; Song Y; Fang X; Gupta N; Serikov V; Lee JW; Matthay MA
Stem Cells; 2010 Dec; 28(12):2229-38. PubMed ID: 20945332
[TBL] [Abstract][Full Text] [Related]
8. Antibacterial responses of retinal Müller glia: production of antimicrobial peptides, oxidative burst and phagocytosis.
Singh PK; Shiha MJ; Kumar A
J Neuroinflammation; 2014 Feb; 11():33. PubMed ID: 24548736
[TBL] [Abstract][Full Text] [Related]
9. Differential TLR activation of murine mesenchymal stem cells generates distinct immunomodulatory effects in EAE.
Vega-Letter AM; Kurte M; Fernández-O'Ryan C; Gauthier-Abeliuk M; Fuenzalida P; Moya-Uribe I; Altamirano C; Figueroa F; Irarrázabal C; Carrión F
Stem Cell Res Ther; 2016 Oct; 7(1):150. PubMed ID: 27724984
[TBL] [Abstract][Full Text] [Related]
10. Mesenchymal stromal cell-secreted CCL2 promotes antibacterial defense mechanisms through increased antimicrobial peptide expression in keratinocytes.
Marx C; Gardner S; Harman RM; Wagner B; Van de Walle GR
Stem Cells Transl Med; 2021 Dec; 10(12):1666-1679. PubMed ID: 34528765
[TBL] [Abstract][Full Text] [Related]
11. Preliminary evaluation of safety and migration of immune activated mesenchymal stromal cells administered by subconjunctival injection for equine recurrent uveitis.
Cassano JM; Leonard BC; Martins BC; Vapniarsky N; Morgan JT; Dow SW; Wotman KL; Pezzanite LM
Front Vet Sci; 2023; 10():1293199. PubMed ID: 38162475
[TBL] [Abstract][Full Text] [Related]
12. Mouse Bone Marrow Sca-1
Naik SK; Padhi A; Ganguli G; Sengupta S; Pati S; Das D; Sonawane A
Infect Immun; 2017 Oct; 85(10):. PubMed ID: 28739828
[No Abstract] [Full Text] [Related]
13. Toll-like receptor activation modulates antimicrobial peptide expression by ocular surface cells.
Redfern RL; Reins RY; McDermott AM
Exp Eye Res; 2011 Mar; 92(3):209-20. PubMed ID: 21195713
[TBL] [Abstract][Full Text] [Related]
14.
Lee DH; Lee EB; Seo JP; Ko EJ
J Vet Sci; 2023 May; 24(3):e37. PubMed ID: 37271505
[TBL] [Abstract][Full Text] [Related]
15. Inflammatory licensed equine MSCs are chondroprotective and exhibit enhanced immunomodulation in an inflammatory environment.
Cassano JM; Schnabel LV; Goodale MB; Fortier LA
Stem Cell Res Ther; 2018 Apr; 9(1):82. PubMed ID: 29615127
[TBL] [Abstract][Full Text] [Related]
16. The mesenchymal stromal cell secretome impairs methicillin-resistant Staphylococcus aureus biofilms via cysteine protease activity in the equine model.
Marx C; Gardner S; Harman RM; Van de Walle GR
Stem Cells Transl Med; 2020 Jul; 9(7):746-757. PubMed ID: 32216094
[TBL] [Abstract][Full Text] [Related]
17. Cathelicidin peptide LL-37 modulates TREM-1 expression and inflammatory responses to microbial compounds.
Amatngalim GD; Nijnik A; Hiemstra PS; Hancock RE
Inflammation; 2011 Oct; 34(5):412-25. PubMed ID: 20811938
[TBL] [Abstract][Full Text] [Related]
18. Interspecies cathelicidin comparison reveals divergence in antimicrobial activity, TLR modulation, chemokine induction and regulation of phagocytosis.
Coorens M; Scheenstra MR; Veldhuizen EJ; Haagsman HP
Sci Rep; 2017 Jan; 7():40874. PubMed ID: 28102367
[TBL] [Abstract][Full Text] [Related]
19. Interaction of Cutibacterium acnes with human bone marrow derived mesenchymal stem cells: a step toward understanding bone implant- associated infection development.
Dubus M; Varin J; Papa S; Rammal H; Chevrier J; Maisonneuve E; Mauprivez C; Mongaret C; Gangloff SC; Reffuveille F; Kerdjoudj H
Acta Biomater; 2020 Mar; 104():124-134. PubMed ID: 31881313
[TBL] [Abstract][Full Text] [Related]
20. Impact of Three Different Serum Sources on Functional Properties of Equine Mesenchymal Stromal Cells.
Pezzanite L; Chow L; Griffenhagen G; Dow S; Goodrich L
Front Vet Sci; 2021; 8():634064. PubMed ID: 33996964
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]